Senior Scientist, Clinical Research, Global Trial Optimization, Merck & Co., Inc.
Gwenn has been working as a member of the GTO group at Merck since 2014. Gwenn is currently responsible for multiple registration protocols in the Keytruda Lung program and serves as the Melanoma indication lead for GTO. At the program level, Gwenn initiated the Keynote Awareness...
Read More →